More info
Novel orally bioavailable inhibitor of respiratory syncytial virus (RSV) fusion, exhibiting a mean IC50 of 1.2 nM against a panel of RSV A and B laboratory strains and clinical isolates with antiviral efficacy in the Balb/C mouse model of RSV infection